| Maria Ebo, PMHNP | |
|
770 Woodlane Rd, Westampton, NJ 08060 | |
| (609) 267-5928 | |
| Not Available |
| Full Name | Maria Ebo |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 5 Years |
| Location | 770 Woodlane Rd, Westampton, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245881192 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LP0808X | Nurse Practitioner - Psychiatric/mental Health | 26NJ00953800 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Virtua Willingboro Hospital | Willingboro, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Center For Family Guidance Pc | 2860396454 | 158 |
News Archive
Research from the University of Southampton has shown a drug, used in combination with chemotherapy to treat advanced colorectal cancer, is not effective in some settings, and indeed may result in more rapid cancer progression.
Withdrawal of life-sustaining support and withholding lifesaving measures (such as CPR) appear to be the primary modes of infant deaths in a neonatal intensive care unit, according to a report in the July issue of Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals.
The U.S. Food and Drug Administration announced today that the agency is recommending removing the breast cancer indication from the label for Avastin (bevacizumab) because the drug has not been shown to be safe and effective for that use.
Researchers in Australia and the United States have advised that the recent decision in Australia to prioritize older vulnerable age groups for vaccination against coronavirus disease 2019 (COVID-19) represents the optimal strategy for reducing deaths caused by the disease.
› Verified 9 days ago
| Entity Name | Center For Family Guidance Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508803388 PECOS PAC ID: 2860396454 Enrollment ID: O20031125000323 |
News Archive
Research from the University of Southampton has shown a drug, used in combination with chemotherapy to treat advanced colorectal cancer, is not effective in some settings, and indeed may result in more rapid cancer progression.
Withdrawal of life-sustaining support and withholding lifesaving measures (such as CPR) appear to be the primary modes of infant deaths in a neonatal intensive care unit, according to a report in the July issue of Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals.
The U.S. Food and Drug Administration announced today that the agency is recommending removing the breast cancer indication from the label for Avastin (bevacizumab) because the drug has not been shown to be safe and effective for that use.
Researchers in Australia and the United States have advised that the recent decision in Australia to prioritize older vulnerable age groups for vaccination against coronavirus disease 2019 (COVID-19) represents the optimal strategy for reducing deaths caused by the disease.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Maria Ebo, PMHNP 770 Woodlane Rd, Westampton, NJ 08060-3804 Ph: (609) 267-5928 | Maria Ebo, PMHNP 770 Woodlane Rd, Westampton, NJ 08060 Ph: (609) 267-5928 |
News Archive
Research from the University of Southampton has shown a drug, used in combination with chemotherapy to treat advanced colorectal cancer, is not effective in some settings, and indeed may result in more rapid cancer progression.
Withdrawal of life-sustaining support and withholding lifesaving measures (such as CPR) appear to be the primary modes of infant deaths in a neonatal intensive care unit, according to a report in the July issue of Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals.
The U.S. Food and Drug Administration announced today that the agency is recommending removing the breast cancer indication from the label for Avastin (bevacizumab) because the drug has not been shown to be safe and effective for that use.
Researchers in Australia and the United States have advised that the recent decision in Australia to prioritize older vulnerable age groups for vaccination against coronavirus disease 2019 (COVID-19) represents the optimal strategy for reducing deaths caused by the disease.
› Verified 9 days ago
Mrs. Joan Ruth Mechlin, APRN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 795 Woodlane Rd Ste 301, Westampton, NJ 08060 Phone: 609-267-1377 Fax: 609-265-9286 | |
Ms. Lauren A Kusznir, ANP-BC, OCN, CHPN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 600 Highland Dr, Suite 624, Westampton, NJ 08060 Phone: 609-304-4872 Fax: 609-265-1307 | |
Jill S Shafi, PMHNP-BC Nurse Practitioner Medicare: May Accept Medicare Assignments Practice Location: 770 Woodlane Rd, Westampton, NJ 08060 Phone: 609-267-5928 | |
Mr. Kevin Philip Wright, APN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 650 Rancocas Rd, Westampton, NJ 08060 Phone: 609-267-7000 | |
Mrs. Sauda Umutesi, RN Nurse Practitioner Medicare: May Accept Medicare Assignments Practice Location: 770 Woodlane Rd, Westampton, NJ 08060 Phone: 609-267-5928 | |
Anna O'kinsky, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 25 Ikea Dr, Westampton, NJ 08060 Phone: 609-267-9339 Fax: 609-267-6655 |